News About: Pharm. Industry
Zuellig, “Novartis is only former minority shareholder which already transferred shares back to us”
Zuellig Pharma Korea announced an official position about its relationship with Novartis, which was indicated at the Ministry of Health and Welfare’s National Inspection.
On the 29th, Zuellig announced “We found unt...
Novartis Korea still with no apology for rebate crisisNovartis Korea avoided responsibility for the recent rebate crisis instead of making an apology.
Assemblyperson Mi-Hyuk Kwon from The Minjoo Party demanded an apology from CEO ...
|
“Janssen Korea violated Narcotics Control Law by advertising ‘Concerta’ to public”An argument was made a multinational pharmaceutical company Janssen Korea was confirmed to violate the Narcotics Control Law for conducting marketing campaigns on people to incr...
|
Pharma industry on first day to enforce Bribery Prohibition Law
On the 28th, the Bribery Prohibition Law will be actively enforced.
It has been 4 years since the Anti-Corruption and Civil Rights Commission gave an administrative notice for the legislation of the act on August 201...
U.S. Biopharmaceutical company, AntriaBio establishes branch in SeoulA biopharmaceutical company located in U.S. Colorado, which is developing a new extended release type of treatment, AntriaBio Inc. announced it will found an affiliate in Seoul ...
|
Dong-A second challenge on global new drug, having similar figure as Sivextro
The second new global drug developed by Dong-A ST is expected to take a momentum to launch soon. The interesting point is that it has taken a very similar walk as the story of the super antibiotic Sivextro.
Accordin...
3 of 10 employees at foreign pharma are women, 1 of 10 works in R&D
3 of 10 employees at multinational pharmaceutical companies branched in the Korean market were surveyed to be women. In addition, 1 of 10 of the employees are working in the R&D field.
According to data conducted by ...
Amgen overcomes insurance benefit for Blincyto
It is expected Amgen will begin to aggressively target the domestic antibody market.
In the ‘Amendment to the Public Announcement about Drugs Prescribed and Administered on Cancer Patients’ notified by the Health Ins...
Multinational companies’ supply of products with less than 6-month expiration date
Multinational pharmaceutical companies have caused issues as constantly providing products with less than 6-month expiration periods to pharmaceutical distribution companies as an excuse of the out-of-stock crisis on ...
“Topic is illegality,” multinational pharmas to stand as witness at National Inspection
Two multinational pharmaceutical companies will be summoned for this year’s national inspection. They are Novartis Korea and Janssen Korea; its topic is ‘illegality.’
The Ruling-Opposition Parties’ Room for National ...
